NCT01859221View on ClinicalTrials.gov

Radiotherapy for Oligometastatic Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

September 13, 2022

Study Completion Date

September 13, 2022

Conditions
Oligometastatic Prostate Cancer
Interventions
RADIATION

Stereotactic radiation

Stereotactic radiation

Trial Locations (1)

32206

University of Florida Proton Therapy Institute, Jacksonville

All Listed Sponsors
lead

University of Florida

OTHER

NCT01859221 - Radiotherapy for Oligometastatic Prostate Cancer | Biotech Hunter | Biotech Hunter